Studies with Bat1 demonstrated that it downregulated production of pro-inflammatory cytokines [22] and polymorphisms of DDX39B/BAT1 linked with reduced activity have also been associated with autoimmune disease [23, 24]. This evidence concerns the gene DDX39B and autoimmune disease.